InspireMD, Inc. (NSPR) Return on equity 2016–2025
InspireMD, Inc. (NSPR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-88.4%FY2025 · since FY2016: -209.2% → -88.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -88.4% | +0.3 pp |
| FY2024 | -88.7% | -38.3 pp |
| FY2023 | -50.4% | +55.9 pp |
| FY2022 | -106.3% | -61.8 pp |
| FY2021 | -44.5% | +42.2 pp |
| FY2020 | -86.7% | +99.8 pp |
| FY2019 | -186.5% | -103.9 pp |
| FY2018 | -82.6% | +226.8 pp |
| FY2017 | -309.4% | -100.3 pp |
| FY2016 | -209.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More NSPR financial trends
NSPR RevenueNSPR Net incomeNSPR Net marginNSPR Gross profitNSPR Gross marginNSPR Operating incomeNSPR Operating marginNSPR Operating cash flowNSPR Free cash flowNSPR Capital expendituresNSPR Stock buybacksNSPR Dividends paidNSPR Total assetsNSPR Total liabilitiesNSPR Shareholders’ equityNSPR overview →